Topspin Fund L.P. 3
3 · Oric Pharmaceuticals, Inc. · Filed Apr 23, 2020
Insider Transaction Report
Form 3
Topspin Fund L.P.
10% Owner
Holdings
Series C Preferred Stock
→ Common Stock (497,809 underlying)- (indirect: See footnote)
Series B Preferred Stock
→ Common Stock (2,268,750 underlying) Series B Preferred Stock
→ Common Stock (231,250 underlying)Series D Preferred Stock
→ Common Stock (314,815 underlying)
Footnotes (3)
- [F1]Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock shall automatically convert into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date.
- [F2]The shares are held of record by Topspin Fund, L.P. LG Management, LLC, the general partner of Topspin Fund, L.P., may be deemed to have voting and dispositive power with respect to the shares. Leo A. Guthart, the managing member of LG Management, LLC, may also be deemed to have voting and dispositive power with respect to the shares. Each of LG Management, LLC and Leo A. Guthart disclaims beneficial ownership of the shares, except to the extent of their respective indirect pecuniary interests in such shares.
- [F3]The shares are held of record by Topspin Biotech Fund II, L.P. LG Management, LLC, the general partner of Topspin Biotech Fund II, L.P., may be deemed to have voting and dispositive power with respect to the shares. Leo A. Guthart, the managing member of LG Management, LLC, may also be deemed to have voting and dispositive power with respect to the shares. Each of LG Management, LLC and Leo A. Guthart disclaims beneficial ownership of the shares, except to the extent of their respective indirect pecuniary interests in such shares.